InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Stahl Neil, Vice-Président Exécutif. Insider active across 1 company, notably Regeneron Pharmaceuticals, INC.. Aggregated, 18 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €187k. History available since 25 February 2021. The latest transaction was filed on 16 December 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Stahl Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
304 shares@ US$730.810.5% of flowCommon StockSEC:0001968202-24-000141:0
466 shares@ US$787.000.8% of flowCommon StockSEC:0001968202-24-000138:0
500 shares0Common StockSEC:0001968202-24-000117:0
100 shares@ US$1,081.830.2% of flowCommon StockSEC:0001968202-24-000115:0
23,638 shares@ US$555.6727.6% of flowCommon StockSEC:0001968202-24-000113:0
1,020 shares0Common StockSEC:0001968202-24-000078:0
100 shares@ US$947.340.2% of flowCommon StockSEC:0001968202-24-000056:0
30,750 shares@ US$399.6625.6% of flowCommon StockSEC:0001968202-24-000054:0
809 shares@ US$843.791.4% of flowCommon StockSEC:0001883850-23-000090:0
400 shares0Common StockSEC:0001968202-23-000040:0
50,000 shares@ US$399.6641.6% of flowCommon StockSEC:0001968202-23-000023:0
1,101 shares0Common StockSEC:0001883850-22-000136:0
330 shares0Common StockSEC:0001883850-22-000119:0
335 shares0Common StockSEC:0001883850-22-000053:0
753 shares@ US$664.341.0% of flowCommon StockSEC:0001708138-21-000104:0
2,926 shares0Common StockSEC:0001708138-21-000093:0
4,605 shares0Common StockSEC:0001883850-21-000018:0
435 shares0Common StockSEC:0001708138-21-000020:0
18 of 18 declarations
About Stahl Neil
STAHL NEIL is Executive Vice-President. He has 18 filings in total, and among the 18 recent filings available, the period runs from 2021-05-18 to 2024-12-18, with 0 EUR of buys and 187173 EUR of sells, and the modal transaction nature is Gift. He is also linked to Regeneron Pharmaceuticals, INC., where his stated role is EVP Research and Development.
